LEXEO THERAPEUTICS INC. - COMMON STOCK

3.2400

16-May-25 16:45:00

15 minutes delayed

Stocks

+0.5400

+20.00%

Today's range

2.6600 - 3.4700

ISIN

N/A

Source

NASDAQ

Lexeo Therapeutics Announces Oversubscribed $95.0 Million Equity Financing

11 Mar 2024 07:30:00 By Nasdaq GlobeNewswire
Lexeo Therapeutics Strengthens Clinical Development Leadership with New Executive Appointments

05 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
Lexeo Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

03 Jan 2024 07:00:00 By Nasdaq GlobeNewswire
Lexeo Therapeutics Granted FDA Fast Track Designation and Orphan Drug Designation for LX2020, an AAV-Based Gene Therapy Candidate for PKP2 Arrhythmogenic Cardiomyopathy (ACM)

18 Dec 2023 07:00:00 By Nasdaq GlobeNewswire
Lexeo Therapeutics Reports Third Quarter 2023 Financial Results and Operational Highlights

11 Dec 2023 07:00:00 By Nasdaq GlobeNewswire

<<
<
1
2
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.